Thermo Fisher (TMO) Stock Forecast & Price Target
0 Followers
TMO Analyst Ratings
Strong Buy
15Buy3Hold0Sell
Based on 18 analysts giving stock ratings to Thermo Fisher in the past 3 months
TMO Stock 12 Month Forecast
Average Price Target
MXN 14,233.93▲(9.76% Upside)Based on 18 Wall Street analysts offering 12 month price targets for Thermo Fisher in the last 3 months. The average price target is MXN 14,233.93 with a high forecast of MXN 15,597.40 and a low forecast of MXN 10,805.43. The average price target represents a 9.76% change from the last price of MXN 12,968.37.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 15.6K
AverageMXN 14.23K
LowMXN 10.81K
Highest Price TargetHighestMXN 15,597.40Average Price TargetMXN 14,233.93Lowest Price TargetLowestMXN 10,805.43
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Luke Sergott | Barclays | MXN 14,563.84 | buy | 12.30%Upside | Reiterated | 11/02/26 | ||
 Unknown AnalystNot Ranked | Guggenheim | MXN 13,906.11 | buy | 7.23%Upside | Reiterated | 11/02/26 | ||
| Avantika Dhabaria | Bank of America Securities | MXN 14,939.68 | buy | 15.20%Upside | Reiterated | 10/30/26 | ||
| David Toung | Argus Research | MXN 10,523.55→MXN 14,657.80 | buy | 13.03%Upside | Assigned | 10/29/26 | ||
| Aristotelis Moutopoulos | DZ BANK AG | MXN 11,838.99→MXN 12,214.83 | hold | -5.81%Downside | Downgraded | 10/23/26 | ||
| Patrick B Donnelly | Citi | MXN 12,872.55→MXN 15,033.64 | buy | 15.93%Upside | Reiterated | 10/23/26 | ||
| Jill Wu | CMB International Securities | MXN 12,402.75→MXN 15,033.64 | buy | 15.93%Upside | Reiterated | 10/23/26 | ||
| Catherine Ramsey Schulte | Robert W. Baird | MXN 13,586.65→MXN 14,206.79 | buy | 9.55%Upside | Reiterated | 10/22/26 | ||
| Daniel Arias | Stifel Nicolaus | MXN 12,214.83→MXN 14,563.84 | buy | 12.30%Upside | Reiterated | 10/22/26 | ||
| Dan Leonard | RBC Capital | MXN 10,899.39→MXN 13,718.19 | hold | 5.78%Upside | Assigned | 10/22/26 | ||
| Daniel Brennan | TD Cowen | MXN 14,281.96→MXN 15,221.56 | buy | 17.37%Upside | Assigned | 10/22/26 | ||
| Doug Schenkel | UBS | MXN 15,033.64 | buy | 15.93%Upside | Reiterated | 10/22/26 | ||
| Casey Woodring | J.P. Morgan | MXN 14,281.96→MXN 15,409.48 | buy | 18.82%Upside | Reiterated | 10/22/26 | ||
| Evie Koslosky | Goldman Sachs | MXN 14,657.80→MXN 15,597.40 | buy | 20.27%Upside | Reiterated | 10/21/26 | ||
| Eve Burstein | Bernstein | MXN 10,805.43 | hold | -16.68%Downside | Assigned | 10/19/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Luke SergottBarclays | BuyReiteratedMXN 14,563.84 | 11/02/26 | 12.30%Upside | ||
| Unknown AnalystGuggenheimNot Ranked | BuyReiteratedMXN 13,906.11 | 11/02/26 | 7.23%Upside | ||
| Avantika DhabariaBank of America Securities | BuyReiteratedMXN 14,939.68 | 10/30/26 | 15.20%Upside | ||
| David ToungArgus Research | BuyAssignedMXN 10,523.55→MXN 14,657.80 | 10/29/26 | 13.03%Upside | ||
| Aristotelis MoutopoulosDZ BANK AG | HoldDowngradedMXN 11,838.99→MXN 12,214.83 | 10/23/26 | -5.81%Downside | ||
| Patrick B DonnellyCiti | BuyReiteratedMXN 12,872.55→MXN 15,033.64 | 10/23/26 | 15.93%Upside | ||
| Jill WuCMB International Securities | BuyReiteratedMXN 12,402.75→MXN 15,033.64 | 10/23/26 | 15.93%Upside | ||
| Catherine Ramsey SchulteRobert W. Baird | BuyReiteratedMXN 13,586.65→MXN 14,206.79 | 10/22/26 | 9.55%Upside | ||
| Daniel AriasStifel Nicolaus | BuyReiteratedMXN 12,214.83→MXN 14,563.84 | 10/22/26 | 12.30%Upside | ||
| Dan LeonardRBC Capital | HoldAssignedMXN 10,899.39→MXN 13,718.19 | 10/22/26 | 5.78%Upside | ||
| Daniel BrennanTD Cowen | BuyAssignedMXN 14,281.96→MXN 15,221.56 | 10/22/26 | 17.37%Upside | ||
| Doug SchenkelUBS | BuyReiteratedMXN 15,033.64 | 10/22/26 | 15.93%Upside | ||
| Casey WoodringJ.P. Morgan | BuyReiteratedMXN 14,281.96→MXN 15,409.48 | 10/22/26 | 18.82%Upside | ||
| Evie KosloskyGoldman Sachs | BuyReiteratedMXN 14,657.80→MXN 15,597.40 | 10/21/26 | 20.27%Upside | ||
| Eve BursteinBernstein | HoldAssignedMXN 10,805.43 | 10/19/26 | -16.68%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Thermo Fisher
3 Months
Success Rate22/30 ratings generated profit
73%
Average Return
+5.00%
Copying Daniel Arias's trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +5.00% per trade.
1 Year
Success Rate18/19 ratings generated profit
95%
Average Return
+21.76%
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 94.74% of your transactions generating a profit, with an average return of +21.76% per trade.
2 Years
Success Rate18/19 ratings generated profit
95%
Average Return
+43.70%
Copying Doug Schenkel's trades and holding each position for 2 Years would result in 94.74% of your transactions generating a profit, with an average return of +43.70% per trade.
TMO Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 30 | 22 | 23 | 24 | 25 |
| Hold | 8 | 6 | 6 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 38 | 28 | 29 | 31 | 32 |
In the current month, TMO has received 25 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. TMO average Analyst price target in the past 3 months is 14,233.93.
TMO Financial Forecast
HighMXN 136.62
ConsensusMXN 134.01
LowMXN 131.54
TMO Earnings Forecast
Next quarter’s earnings estimate for TMO is MXN 134.01 with a range of MXN 131.54 to MXN 136.62. The previous quarter’s EPS was MXN 125.53. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 244B
ConsensusMXN 241B
LowMXN 239B
TMO Sales Forecast
Next quarter’s sales forecast for TMO is MXN 241.34B with a range of MXN 238.94B to MXN 244.06B. The previous quarter’s sales results were MXN 228.08B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
TMO Stock Forecast FAQ
What is MX:TMO’s average 12-month price target, according to analysts?
Based on analyst ratings, Thermo Fisher’s 12-month average price target is Mex$14,233.93.
What is MX:TMO’s upside potential, based on the analysts’ average price target?
Thermo Fisher has 9.76% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Thermo Fisher a Buy, Sell or Hold?
Thermo Fisher has a consensus rating of Strong Buy, which is based on 15 buy ratings, 3 hold ratings and 0 sell ratings.
What is Thermo Fisher’s share price target?
The average share price target for Thermo Fisher is Mex$14,233.93. This is based on 18 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$15,597.40, and the lowest forecast is Mex$10,805.43. The average share price target represents a 9.76% increase from the current price of Mex$12,968.37.
What do analysts say about Thermo Fisher?
Thermo Fisher’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Street analysts.
How can I buy shares of Thermo Fisher?
To buy shares of MX:TMO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
